Navigation Links
FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria
Date:2/19/2008

ogy (AAAAI) suggest that indoor and outdoor allergies affect as many as 40 million people in the United States.

Seasonal allergic rhinitis (SAR), commonly referred to as "hay fever" or "outdoor allergies," is the most common form of allergic rhinitis. By definition, SAR includes allergies to seasonal pollens like grass, trees, and weeds, as well as mold. Perennial Allergic Rhinitis (PAR) is sometimes referred to as "year round" or "indoor allergies" and is characterized by allergic symptoms that last longer than four weeks. House dust mites, animal dander, and mold most commonly trigger PAR. Chronic Idiopathic Urticaria (CIU) is most commonly known as "chronic hives of unknown origin" and is defined as the occurrence of daily, or almost daily, wheals and itching for at least six weeks with no obvious causes.

About XYZAL(R)

Indications and Important Safety Information

XYZAL(R) is indicated for the relief of symptoms associated with allergic rhinitis (seasonal and perennial) and the treatment of uncomplicated skin manifestations of chronic idiopathic urticaria in adults and children 6 years of age and older.

The use of XYZAL(R) is contraindicated in: patients with a known hypersensitivity to levocetirizine or any of the ingredients of XYZAL or to cetirizine (observed reactions range from urticaria to anaphylaxis); patients with end-stage renal impairment at less than 10 mL/min creatinine clearance or patients undergoing hemodialysis; and pediatric patients aged 6 to 11 years with impaired renal function.

Patients should be cautioned against engaging in hazardous occupations requiring complete mental alertness and motor coordination, such as operating machinery or driving a motor vehicle, after ingestion of XYZAL(R). Concurrent use of XYZAL(R) with alcohol or other central nervous system (CNS) depressants should be avoided because additional reductions in alertness and additional impairment of CNS performance may occur.


'/>"/>

SOURCE sanofi-aventis
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
3. FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
4. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
5. FDA Approves MiddleBrooks Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
6. Tourtellotte Solutions Blazes Trail with New Release of Clinical Trial Supply Chain Simulator
7. Image Solutions, Inc. Acquires Zurich Biostatistics, Inc.
8. Data from Three Clinical Trials for Perforomist(TM) Inhalation Solution to be Presented at CHEST 2007 on October 24, 2007
9. Studies Show Body Mass Index Has No Effect on Resolution and Healing of GERD Symptoms
10. Facet Solutions Enjoys Continued Clinical Success With the Anatomic Facet Replacement System (AFRS(TM))
11. Facet Solutions AFRS(TM) Demonstrates Biomechanical Advantages Over Dynamic Stabilization in Independent Testing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2009)... Dec. 6 The FDA has approved ... breast cancer sooner and faster. The SonoCine Automated ... only one facility in Arizona - Arizona Breastnet, ... as a breast cancer screening tool to enhance ... been used for diagnostic purposes - not for ...
(Date:12/4/2009)... A simple, inexpensive computer tool that measures volume ... lungs picked up by a CT scanner can rule ... doctors to diagnose true cancers with fewer, less expensive ... ,, The new diagnostic guidelines are described in a ...
(Date:12/4/2009)... Dec. 4 Vermillion, Inc. (VRML) (Pink Sheets: VRMLQ) announced ... Plan of Reorganization and related amended Disclosure Statement with the ... ,, A hearing to consider the adequacy of the ... the hearing on the confirmation of the Plan scheduled for ...
Breaking Medicine Technology:New FDA Approved Breast Cancer Screening Tool 2New FDA Approved Breast Cancer Screening Tool 3European Lung Cancer Screening Trial Demonstrates New Inexpensive Strategy for Improving Accuracy of Diagnosis 2Vermillion Files Amended Plan of Reorganization and Exchanges Debt 2Vermillion Files Amended Plan of Reorganization and Exchanges Debt 3Lumension Webinar Highlights How Organizations Can Protect Information and Comply with Data Handling Procedures 51423 1Lumension Webinar Highlights How Organizations Can Protect Information and Comply with Data Handling Procedures 51423 2Lumension Webinar Highlights How Organizations Can Protect Information and Comply with Data Handling Procedures 51423 3Scientist Presents Data Countering Medicine 26apos 3Bs Claim of Increasing Life Span In Midst Of Debate Over Medical Insurance 51420 1Scientist Presents Data Countering Medicine 26apos 3Bs Claim of Increasing Life Span In Midst Of Debate Over Medical Insurance 51420 2Scientist Presents Data Countering Medicine 26apos 3Bs Claim of Increasing Life Span In Midst Of Debate Over Medical Insurance 51420 3Scientist Presents Data Countering Medicine 26apos 3Bs Claim of Increasing Life Span In Midst Of Debate Over Medical Insurance 51420 4Select Telecom Adds Surveillance System Installation and Maintenance Services Receives New York State License 51417 1Select Telecom Adds Surveillance System Installation and Maintenance Services Receives New York State License 51417 2
(Date:12/6/2009)... Fox, LLP says dangerous substances such as asbestos have been found ... ... York, NY (PRWEB) December 6, 2009 -- As parents shop for ... reports of recalls due to lead paint or asbestos contamination, says ... visit hospital emergency rooms each year due to toy-related injuries,” says ...
(Date:12/5/2009)... Dec. 5 ,, What: Cuts for ... difference in the fight against cancer and other terminal illnesses ... be donated to St. Jude Children,s Research Hospital. Guests will ... a delectable and savory Vietnamese restaurant in Falls Church for ...
(Date:12/5/2009)... NEW ORLEANS, Dec. 5 Leukemia and myeloproliferative ... Research presented today at the 51st Annual Meeting ... new treatment options and improved diagnostic methods for ... leukemia, infant acute lymphoblastic leukemia, and myelofibrosis that ...
(Date:12/5/2009)... Center helps companies develop and test their cleaning processes. The technology ... of industries and solve problems for customers relating to cleaning parts, ... ... 2009 -- Midbrook, Inc , a Jackson, MI-based company, is ...
(Date:12/5/2009)... unusual places, and to do everything from growing mushrooms, making wine to ... ... would have thought that your wine, water and vegetables would have come ... new line of turbines, for industry end users, not wind farms. ...
Breaking Medicine News(10 mins):Health News:Belluck & Fox Law Firm Urges Caution When Buying Toys This Holiday Season 2Health News:Belluck & Fox Law Firm Urges Caution When Buying Toys This Holiday Season 3Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 2Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 3Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 4Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 5Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 6Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 7Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 9Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 2Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 3Health News:Distributor Announces New Applications for Wind Turbines 2Health News:Distributor Announces New Applications for Wind Turbines 3
... Standard in More Efficient Registration and Revenue Cycle ... Group, Inc. (SSI) announced today that it has ... offer an enhancement to an SSI product. SSI,s ... Enterprise Tracking ) will be powered by Boston ...
... May 19 Gold Star Resources Corp. (OTC Bulletin ... announced today the launch of a non-profit ... the Canadian company,s commitment to contributing to the social ... permit area within the Roberts and Bassa Basins of ...
... have created a method of quickly identifying large numbers of ... called shRNA that turns genes on and off. ... create a library of 22,000 of these "on-off" switches for ... the world, with ultimate impacts on the study of the ...
... High Throughput Research Processes - , HOPKINTON, Mass., May ... CALP ), a leading provider of tools and services ... a collaboration with the Peter MacCallum Cancer Centre (PMCC), ... Staccato automation system to perform oncology related lab discovery ...
... capabilities such as geo-spatial search, content mash-ups and social ... Vivisimo ( www.vivisimo.com ), a leading provider of enterprise ... international health and care company with more than 10 ... Vivisimo Velocity Search Platform to power ...
... May 19 Fred A. Baughman Jr., MD today announced the ... by the Surgeon General of the Army. , ... "Vets taking Post Traumatic Stress Disorder drugs die in sleep," Baughman ... why they were likely, the "tip of an iceberg." , ...
Other Medicine News:Health News:SSI Group to Integrate Boston Software Systems' Boston WorkStation Into ClickON PREVENT 2Health News:SSI Group to Integrate Boston Software Systems' Boston WorkStation Into ClickON PREVENT 3Health News:Gold Star Resources Corp. Launches Humanitarian Society to Aid Liberian People 2Health News:UCSF creates fast, affordable tool for finding gene 'on-off' switches 2Health News:Peter MacCallum Cancer Centre Expands Cancer Research Efforts with Automation Tool from Caliper Life Sciences 2Health News:Peter MacCallum Cancer Centre Expands Cancer Research Efforts with Automation Tool from Caliper Life Sciences 3Health News:Vivisimo Powers Site Search on Bupa's Leading Health Information Websites Worldwide 2Health News:Fred A. Baughman Jr., MD Announces: Vets' Sudden Cardiac Deaths Are Not Suicides or Overdoses 2
... The Matrix Perimeter utilizes Welch ... a significant breakthrough in visual field ... capabilities, tools to characterize glaucoma and ... Humphrey FDT Perimeter, the Matrix doubles ...
... IMAGE1 is the first completely digital camera ... in the field of endoscopic camera systems. ... the first time, facilitates the fully digital ... quality using an A/D converter, as well ...
... been a standard requirement for ... during laser procedures, however, many ... that smoke plume generated from ... as smoke plume generated from ...
Erbium Laser with Sapphire Erbium Handpiece for Dermatological and Cosmetic Surgery...
Medicine Products: